{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T16:33:31Z","timestamp":1787070811961,"version":"build-2736575974"},"reference-count":48,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Despite the improved outcomes in acute lymphoblastic leukemia (ALL), drug resistance remains a major challenge. This study provides the first overview of global research trends in pediatric ALL drug resistance, highlighting emerging directions.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Materials and Methods:<\/jats:title>\n                    <jats:p>In this bibliometric study, related keywords such as acute lymphoblastic leukemia, pediatric, and drug resistance were searched in the Web of Science (WOS) Core Collection. The retrieved papers were subjected to bibliometric analysis and visualization using Biblioshiny and VOSviewer.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      A total of 432 original papers and 94 review articles by 2546 researchers from 48 countries were analyzed. The United States contributed 148 articles, which received 9569 citations. Bradford\u2019s law identified nine core sources, with\n                      <jats:italic toggle=\"yes\">Blood<\/jats:italic>\n                      being the most impactful (41 papers and 4900 total citations). \u201c\n                      <jats:italic toggle=\"yes\">Oncology<\/jats:italic>\n                      \u201d was the top WOS category. Pieters was the most influential author, contributing 87 publications in the field. The most frequent keywords highlighted the biological contributors to drug resistance, including altered glucocorticoid response, overexpression of drug-efflux proteins (particularly P-gp), and the critical role of miRNAs and other genetic mediators in leukemic cell drug resistance. Based on the thematic map, the keywords of the motor themes were clofarabine, nelarabine, daunorubicin, vincristine, and microRNA, illustrating the need for further investigation of their clinical applications and the underlying mechanisms of resistance to these agents.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>Medical researchers have been attracted to different aspects of drug resistance in pediatric ALL. This bibliometric analysis reflects the current state of research on drug resistance in pediatric ALL and draws attention to critical concerns that require further investigation.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/abr.abr_650_24","type":"journal-article","created":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T10:00:17Z","timestamp":1761904817000},"update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["A Bibliometric Analysis of Drug Resistance in Pediatric Acute Lymphoblastic Leukemia"],"prefix":"10.4103","volume":"14","author":[{"given":"Alireza","family":"Khanahmad","sequence":"first","affiliation":[{"name":"Student Research Committee, Afzalipour Faculty of Medicine, Kerman University of Medical Sciences, Kerman, Iran"},{"name":"Department of Hematology and Medical Laboratory Sciences, Faculty of Allied Medicine, Kerman University of Medical Sciences, Kerman, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Hossein","family":"Khazaee-Nasirabadi","sequence":"additional","affiliation":[{"name":"Department of Medical Laboratory Sciences, School of Allied Medical Sciences, Jiroft University of Medical Sciences, Jiroft, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahshid","family":"Lotfi","sequence":"additional","affiliation":[{"name":"Research Center for Health Technology Assessment and Medical Informatics, School of Public Health, Shahid Sadoughi University of Medical Sciences, Yazd, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amir","family":"Hami","sequence":"additional","affiliation":[{"name":"Department of Medical Library and Information Sciences, School of Health Management and Information Sciences, Iran University of Medical Sciences, Tehran, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,10]]},"reference":[{"key":"R1-20251130","doi-asserted-by":"crossref","first-page":"e577","DOI":"10.1038\/bcj.2017.53","article-title":"Acute lymphoblastic leukemia: A comprehensive review and 2017 update","volume":"7","author":"Terwilliger","year":"2017","journal-title":"Blood Cancer J"},{"key":"R2-20251130","first-page":"1045","article-title":"Evaluation of plasma activity level of anticoagulant proteins in patients with acute lymphoblastic leukemia in Shafa hospital Ahwaz 2010","volume":"16","author":"Jalali","year":"2012","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"R3-20251130","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1136\/archdischild-2016-311251","article-title":"Clinical presentation of childhood leukaemia: A systematic review and meta-analysis","volume":"101","author":"Clarke","year":"2016","journal-title":"Arch Dis Child"},{"key":"R4-20251130","doi-asserted-by":"crossref","first-page":"3431","DOI":"10.1007\/s00277-023-05389-x","article-title":"Causes of death and treatment-related mortality in newly diagnosed childhood acute lymphoblastic leukemia treatment with Chinese Children\u2019s Cancer Group study ALL-2015","volume":"102","author":"Liu","year":"2023","journal-title":"Ann Hematol"},{"key":"R5-20251130","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1007\/s11899-009-0021-6","article-title":"Novel therapies for relapsed acute lymphoblastic leukemia","volume":"4","author":"Fullmer","year":"2009","journal-title":"Curr Hematol Malig Rep"},{"key":"R6-20251130","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1186\/s12943-024-01967-3","article-title":"Drug resistance in ovarian cancer: From mechanism to clinical trial","volume":"23","author":"Wang","year":"2024","journal-title":"Mol Cancer"},{"key":"R7-20251130","doi-asserted-by":"crossref","first-page":"100796","DOI":"10.1016\/j.drup.2021.100796","article-title":"Anticancer drug resistance: An update and perspective","volume":"59","author":"Nussinov","year":"2021","journal-title":"Drug Resist Updat"},{"key":"R8-20251130","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1038\/s41586-019-1730-1","article-title":"A view on drug resistance in cancer","volume":"575","author":"Vasan","year":"2019","journal-title":"Nature"},{"key":"R9-20251130","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1186\/s13643-023-02410-2","article-title":"Preliminary guideline for reporting bibliometric reviews of the biomedical literature (BIBLIO): A minimum requirements","volume":"12","author":"Montazeri","year":"2023","journal-title":"Syst Rev"},{"key":"R10-20251130","first-page":"1","article-title":"Analysis of retracted articles in the field of immunology: A scientometric study","volume":"4","author":"Hami","year":"2023","journal-title":"J Med Libr Inf Sci"},{"key":"R11-20251130","doi-asserted-by":"crossref","first-page":"21582440231158562","DOI":"10.1177\/21582440231158562","article-title":"Mapping the literature on academic publishing: A bibliometric analysis on WOS","volume":"13","author":"Yan","year":"2023","journal-title":"Sage Open"},{"key":"R12-20251130","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/j.joi.2017.08.007","article-title":"Bibliometrix: An R-tool for comprehensive science mapping analysis","volume":"11","author":"Aria","year":"2017","journal-title":"J Informetr"},{"key":"R13-20251130","doi-asserted-by":"crossref","first-page":"1002667","DOI":"10.3389\/fonc.2022.1002667","article-title":"Global research trends on anti-PD-1\/anti-PD-L1 immunotherapy for triple-negative breast cancer: A scientometric analysis","volume":"12","author":"Wu","year":"2023","journal-title":"Front Oncol"},{"key":"R14-20251130","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1159\/000493251","article-title":"Top 100 most influential articles in the field of myeloid neoplasms: A bibliometric study","volume":"141","author":"Iqbal","year":"2019","journal-title":"Acta Haematol"},{"key":"R15-20251130","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.3389\/fphar.2019.01100","article-title":"The top 100 highly cited original articles on immunotherapy for childhood leukemia","volume":"10","author":"Zhong","year":"2019","journal-title":"Front Pharmacol"},{"key":"R16-20251130","doi-asserted-by":"crossref","first-page":"981406","DOI":"10.3389\/fonc.2022.981406","article-title":"Trends in metabolic signaling pathways of tumor drug resistance: A scientometric analysis","volume":"12","author":"Jiang","year":"2022","journal-title":"Front Oncol"},{"key":"R17-20251130","first-page":"1","article-title":"Mapping of scientific articles on Leukemia: A scientometric study","author":"Shilpa","year":"2019","journal-title":"Libr Philos Pract"},{"key":"R18-20251130","doi-asserted-by":"crossref","first-page":"S57","DOI":"10.1016\/j.htct.2022.02.001","article-title":"The landscape of hematology research in Brazil: An analysis of data from citation databases","volume":"45","author":"De Paula","year":"2023","journal-title":"Hematol Transfus Cell Ther"},{"key":"R20-20251130","doi-asserted-by":"crossref","first-page":"1","DOI":"10.5045\/br.2020.55.1.1","article-title":"Bibliometric analysis of studies about acute myeloid leukemia conducted globally from 1999 to 2018","volume":"55","author":"Seo","year":"2020","journal-title":"Blood Res"},{"key":"R21-20251130","doi-asserted-by":"crossref","first-page":"2267865","DOI":"10.1080\/21645515.2023.2267865","article-title":"Current status and future prospects of chimeric antigen receptor-T cell therapy in lymphoma research: A bibliometric analysis","volume":"19","author":"Ou","year":"2023","journal-title":"Hum Vaccin Immunother"},{"key":"R22-20251130","doi-asserted-by":"crossref","first-page":"826703","DOI":"10.3389\/fonc.2022.826703","article-title":"Management of chronic myeloid leukemia and pregnancy: A bibliometric analysis (2000-2020)","volume":"12","author":"Wang","year":"2022","journal-title":"Front Oncol"},{"key":"R23-20251130","doi-asserted-by":"crossref","first-page":"957370","DOI":"10.3389\/fonc.2022.957370","article-title":"The research progress of targeted therapy in acute myeloid leukemia based on bibliometric analysis","volume":"12","author":"Huang","year":"2022","journal-title":"Front Oncol"},{"key":"R24-20251130","doi-asserted-by":"crossref","first-page":"1291195","DOI":"10.3389\/fphar.2023.1291195","article-title":"A global bibliometric and visualized analysis of the links between the autophagy and acute myeloid leukemia","volume":"14","author":"Gao","year":"2024","journal-title":"Front Pharmacol"},{"key":"R25-20251130","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.7150\/jca.68453","article-title":"Global research trends on the treatment of diffuse large B-cell lymphoma: A bibliometric and visualized study","volume":"13","author":"Duan","year":"2022","journal-title":"J Cancer"},{"key":"R26-20251130","first-page":"e58","article-title":"The scientometric analysis of highly-cited articles in hematology published from 2010 to 2020","volume":"5","author":"Hami","year":"2024","journal-title":"J Med Libr Inf Sci"},{"key":"R27-20251130","doi-asserted-by":"crossref","first-page":"2847","DOI":"10.1001\/jama.287.21.2847","article-title":"Journal prestige, publication bias, and other characteristics associated with citation of published studies in peer-reviewed journals","volume":"287","author":"Callaham","year":"2002","journal-title":"JAMA"},{"key":"R28-20251130","first-page":"9","article-title":"Scientometric analysis of leukemia research output during 2010-2019","volume":"1","author":"Ayyanar","year":"2021","journal-title":"Emperor Int J Libr Inf Technol Res"},{"key":"R29-20251130","first-page":"98","article-title":"A scientometric visualization of 32 years of leukemia research in India","volume":"43","author":"Yumnam","year":"2024","journal-title":"Sci Technol Libr"},{"key":"R30-20251130","doi-asserted-by":"crossref","first-page":"36","DOI":"10.5897\/IJLIS2016.0661","article-title":"Application of Bradfords law in the field of botany literature from 2005 to 2014: A citation analysis","volume":"8","author":"Neelamma","year":"2016","journal-title":"Int J Libr Inf Sci"},{"key":"R33-20251130","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.trecan.2023.09.003","article-title":"Non-genetic mechanisms of drug resistance in acute leukemias","volume":"10","author":"Calderon","year":"2024","journal-title":"Trends Cancer"},{"key":"R34-20251130","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S1470-2045(08)70314-0","article-title":"Early T-cell precursor leukaemia: A subtype of very high-risk acute lymphoblastic leukaemia","volume":"10","author":"Coustan-Smith","year":"2009","journal-title":"Lancet Oncol"},{"key":"R35-20251130","doi-asserted-by":"crossref","first-page":"2938","DOI":"10.1200\/JCO.2014.59.1636","article-title":"Childhood acute lymphoblastic leukemia: Progress through collaboration","volume":"33","author":"Pui","year":"2015","journal-title":"J Clin Oncol"},{"key":"R36-20251130","first-page":"3310","article-title":"Improved outcome in childhood acute lymphoblastic leukemia despite reduced use of anthracyclines and cranial radiotherapy: Results of trial ALL-BFM 90","volume":"95","author":"Schrappe","year":"2000","journal-title":"Blood"},{"key":"R37-20251130","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1056\/NEJMoa033513","article-title":"Gene-expression patterns in drug-resistant acute lymphoblastic leukemia cells and response to treatment","volume":"351","author":"Holleman","year":"2004","journal-title":"N Engl J Med"},{"key":"R38-20251130","doi-asserted-by":"crossref","first-page":"2142","DOI":"10.1038\/leu.2008.251","article-title":"Factors influencing survival after relapse from acute lymphoblastic leukemia: A Children\u2019s Oncology Group study","volume":"22","author":"Nguyen","year":"2008","journal-title":"Leukemia"},{"key":"R39-20251130","doi-asserted-by":"crossref","first-page":"e205","DOI":"10.1016\/S1470-2045(12)70580-6","article-title":"Relapsed childhood acute lymphoblastic leukaemia","volume":"14","author":"Bhojwani","year":"2013","journal-title":"Lancet Oncol"},{"key":"R40-20251130","first-page":"1209","article-title":"Prednisone response is the strongest predictor of treatment outcome in infant acute lymphoblastic leukemia","volume":"94","author":"Do\u0308rdelmann","year":"1999","journal-title":"Blood, J Am Soc Hematol"},{"key":"R41-20251130","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1172\/JCI39987","article-title":"Induction of autophagy-dependent necroptosis is required for childhood acute lymphoblastic leukemia cells to overcome glucocorticoid resistance","volume":"120","author":"Bonapace","year":"2010","journal-title":"J Clin Invest"},{"key":"R42-20251130","doi-asserted-by":"crossref","first-page":"r105","DOI":"10.1186\/gb-2013-14-9-r105","article-title":"Genome-wide signatures of differential DNA methylation in pediatric acute lymphoblastic leukemia","volume":"14","author":"Nordlund","year":"2013","journal-title":"Genome Biol"},{"key":"R43-20251130","doi-asserted-by":"crossref","first-page":"3616","DOI":"10.1200\/JCO.2003.10.116","article-title":"Childhood T-cell acute lymphoblastic leukemia: The Dana-Farber Cancer Institute acute lymphoblastic leukemia consortium experience","volume":"21","author":"Goldberg","year":"2003","journal-title":"J Clin Oncol"},{"key":"R44-20251130","first-page":"897","article-title":"Multidrug resistance of cancer cells and the vital role of P-glycoprotein","volume":"12","author":"Karthika","year":"2022","journal-title":"Life (Basel)"},{"key":"R45-20251130","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/j.bbrc.2004.06.016","article-title":"Mechanisms of cross-resistance between nucleoside analogues and vincristine or daunorubicin in leukemic cells","volume":"320","author":"L\u00f6fgren","year":"2004","journal-title":"Biochem Biophys Res Commun"},{"key":"R46-20251130","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1002\/cam4.1323","article-title":"Clofarabine exerts antileukemic activity against cytarabine-resistant B-cell precursor acute lymphoblastic leukemia with low deoxycytidine kinase expression","volume":"7","author":"Huang","year":"2018","journal-title":"Cancer Med"},{"key":"R47-20251130","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1111\/j.1365-2141.2007.06527.x","article-title":"In vitro cytotoxicity of nelarabine, clofarabine and flavopiridol in paediatric acute lymphoblastic leukaemia","volume":"137","author":"Beesley","year":"2007","journal-title":"Br J Haematol"},{"key":"R48-20251130","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/s00280-021-04373-4","article-title":"Drug resistance to nelarabine in leukemia cell lines might be caused by reduced expression of deoxycytidine kinase through epigenetic mechanisms","volume":"89","author":"Yoshida","year":"2022","journal-title":"Cancer Chemother Pharmacol"},{"key":"R49-20251130","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1186\/s12885-020-07469-x","article-title":"Venetoclax and alvocidib are both cytotoxic to acute myeloid leukemia cells resistant to cytarabine and clofarabine","volume":"20","author":"Nishi","year":"2020","journal-title":"BMC Cancer"},{"key":"R50-20251130","first-page":"5512907","article-title":"Extracellular vesicle\u2013derived microRNAs: A deep review of the latest literature investigating their role in drug resistance, prognosis, and microenvironment interactions in hematologic malignancies","volume":"2025","author":"Bazi","year":"2025","journal-title":"Eur J Cancer Care"},{"key":"R51-20251130","doi-asserted-by":"crossref","first-page":"3429","DOI":"10.31557\/APJCP.2020.21.11.3429","article-title":"Expression of microRNA-181a and microRNA-196b in Egyptian pediatric acute lymphoblastic leukemia","volume":"21","author":"Shafik","year":"2020","journal-title":"Asian Pac J Cancer Prev"}],"container-title":["Advanced Biomedical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/abr.abr_650_24","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T15:37:01Z","timestamp":1787067421000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/abr.abr_650_24"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":48,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.4103\/abr.abr_650_24","relation":{},"ISSN":["2277-9175"],"issn-type":[{"value":"2277-9175","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"2024-12-17","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-08-18","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}